PL342339A1 - Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy - Google Patents

Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy

Info

Publication number
PL342339A1
PL342339A1 PL99342339A PL34233999A PL342339A1 PL 342339 A1 PL342339 A1 PL 342339A1 PL 99342339 A PL99342339 A PL 99342339A PL 34233999 A PL34233999 A PL 34233999A PL 342339 A1 PL342339 A1 PL 342339A1
Authority
PL
Poland
Prior art keywords
benign prostatic
prostatic hypertrophy
novel substituted
treating benign
aryl piperazines
Prior art date
Application number
PL99342339A
Other languages
English (en)
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PL342339A1 publication Critical patent/PL342339A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL99342339A 1998-02-20 1999-02-19 Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy PL342339A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
PL342339A1 true PL342339A1 (en) 2001-06-04

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99342339A PL342339A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy

Country Status (23)

Country Link
US (1) US6218396B1 (enExample)
EP (1) EP1054868B1 (enExample)
JP (1) JP2002503724A (enExample)
KR (1) KR100591028B1 (enExample)
CN (1) CN1121390C (enExample)
AR (1) AR014626A1 (enExample)
AT (1) ATE250580T1 (enExample)
AU (1) AU766398B2 (enExample)
BR (1) BR9909647A (enExample)
CZ (1) CZ294136B6 (enExample)
DE (1) DE69911582T2 (enExample)
DK (1) DK1054868T3 (enExample)
ES (1) ES2209468T3 (enExample)
HU (1) HUP0100781A3 (enExample)
IL (2) IL137954A0 (enExample)
NO (1) NO317103B1 (enExample)
NZ (1) NZ506462A (enExample)
PL (1) PL342339A1 (enExample)
PT (1) PT1054868E (enExample)
TR (1) TR200003220T2 (enExample)
TW (1) TW565555B (enExample)
WO (1) WO1999042448A1 (enExample)
ZA (1) ZA991315B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984777B1 (en) * 1997-05-12 2003-09-17 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
HUP0302893A3 (en) 2000-08-08 2006-04-28 Ortho Mcneil Pharm Inc Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
CN1589153A (zh) * 2001-12-28 2005-03-02 武田药品工业株式会社 排尿紊乱的预防或治疗
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2535330A3 (en) * 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN102066327B (zh) * 2008-04-23 2013-05-29 武田药品工业株式会社 亚氨基吡啶衍生物及其用途
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine

Also Published As

Publication number Publication date
DK1054868T3 (da) 2003-12-22
AR014626A1 (es) 2001-03-28
TR200003220T2 (tr) 2001-04-20
ES2209468T3 (es) 2004-06-16
HK1030776A1 (en) 2001-05-18
KR100591028B1 (ko) 2006-06-22
NO20004141D0 (no) 2000-08-18
KR20010041115A (ko) 2001-05-15
CN1291188A (zh) 2001-04-11
JP2002503724A (ja) 2002-02-05
EP1054868B1 (en) 2003-09-24
WO1999042448A1 (en) 1999-08-26
TW565555B (en) 2003-12-11
CZ294136B6 (cs) 2004-10-13
IL137954A (en) 2007-06-03
BR9909647A (pt) 2000-11-21
PT1054868E (pt) 2004-01-30
NO317103B1 (no) 2004-08-09
NO20004141L (no) 2000-10-19
ZA991315B (en) 2000-11-20
ATE250580T1 (de) 2003-10-15
IL137954A0 (en) 2001-10-31
CN1121390C (zh) 2003-09-17
US6218396B1 (en) 2001-04-17
AU766398B2 (en) 2003-10-16
DE69911582T2 (de) 2005-09-15
DE69911582D1 (de) 2003-10-30
AU3302599A (en) 1999-09-06
CZ20003044A3 (cs) 2001-04-11
EP1054868A1 (en) 2000-11-29
HUP0100781A2 (hu) 2001-08-28
NZ506462A (en) 2003-07-25
HUP0100781A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
DE69902536D1 (en) Polymorphe form von clopidogrel-hydrogenosulfat
HUP9902489A3 (en) Detergent cosmetical composition and its use
EP0885950A4 (en) TENSIDE COMPOSITION
PL348722A1 (en) Environmentally compatible processes compositions and materials treated thereby
SG90712A1 (en) Power amplifier
SG98369A1 (en) Power amplifier
GB9812181D0 (en) Personal washing compositions
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
PL333004A1 (en) Conjugates useful in treating prostatic gland carcinoma
EP0885951A4 (en) TENSIDE COMPOSITION
EP1056456A4 (en) R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
ZA981600B (en) Methods and compositions for treating stickies
GB9803804D0 (en) Improvements in chemical compositions
EP1056457A4 (en) S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
PL340768A1 (en) Conjugates useful in treating prostatic carcinoma
PL342339A1 (en) Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy
AP9901684A0 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
EP0462668A3 (en) New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents
EP1073333A4 (en) S-RABEPRAZOL COMPOSITIONS AND METHODS
EP0633781A4 (en) COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY.
EP1096668A4 (en) POWER CONVERTERS
GB9804063D0 (en) Power amplifier
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
AU6334399A (en) Water-softening and detergent compositions
EP1073332A4 (en) R-RABEPRAZOL COMPOSITIONS AND METHODS

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)